N. ERMİŞ Et Al. , "The effect of angiotensin II type 2 receptor agonist treatment on doxorubicin induced heart failure," Congress of the European-Society-of-Cardiology (ESC) , vol.37, Rome, Italy, pp.1318, 2016
ERMİŞ, N. Et Al. 2016. The effect of angiotensin II type 2 receptor agonist treatment on doxorubicin induced heart failure. Congress of the European-Society-of-Cardiology (ESC) , (Rome, Italy), 1318.
ERMİŞ, N., ÖZHAN, O., Ulutas, Z., VARDI, N., ÇOLAK, C., & PARLAKPINAR, H., (2016). The effect of angiotensin II type 2 receptor agonist treatment on doxorubicin induced heart failure . Congress of the European-Society-of-Cardiology (ESC) (pp.1318). Rome, Italy
ERMİŞ, NECİP Et Al. "The effect of angiotensin II type 2 receptor agonist treatment on doxorubicin induced heart failure," Congress of the European-Society-of-Cardiology (ESC), Rome, Italy, 2016
ERMİŞ, NECİP Et Al. "The effect of angiotensin II type 2 receptor agonist treatment on doxorubicin induced heart failure." Congress of the European-Society-of-Cardiology (ESC) , Rome, Italy, pp.1318, 2016
ERMİŞ, N. Et Al. (2016) . "The effect of angiotensin II type 2 receptor agonist treatment on doxorubicin induced heart failure." Congress of the European-Society-of-Cardiology (ESC) , Rome, Italy, p.1318.
@conferencepaper{conferencepaper, author={NECİP ERMİŞ Et Al. }, title={The effect of angiotensin II type 2 receptor agonist treatment on doxorubicin induced heart failure}, congress name={Congress of the European-Society-of-Cardiology (ESC)}, city={Rome}, country={Italy}, year={2016}, pages={1318} }